Macrophages May Promote Progression of Systemic Sclerosis, Study Shows

Macrophages May Promote Progression of Systemic Sclerosis, Study Shows
0
(0)

New research establishes a link between immune cells, known as macrophages, and systemic sclerosis progression. The study showed that gene expression in macrophages from systemic sclerosis patients is altered, including higher activity of the susceptibility gene GSDMA.

The study “Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk” was published in the journal Annals of Rheumatic Diseases.

Previous studies have identified several genes linked to an increased susceptibility to systemic sclerosis, but which cells carried these variants remained poorly understood.

Now, an international collaboration identified a group of immune cells – macrophages – as potential perpetrators of disease progression.

Researchers performed a genetic and RNA sequencing analysis in macrophages from 57 systemic sclerosis patients and from 15 healthy people (controls), and looked at changes in gene expression that occurred especially in the systemic sclerosis cells.

The team found a different gene activity pattern between systemic sclerosis and healthy controls.

“We identified 602 genes upregulated 
[higher expression] and downregulated [lower expression] in SSc [systemic sclerosis] macrophages that were significantly enriched for genes previously implicated in SSc susceptibility,” the researchers wrote.

The analysis also revealed an unknown role for macrophages in having a higher expression of the GSDMA and GRB10 genes, which were previously identified as associated with systemic sclerosis susceptibility.

“Investigating how genetic variation is responsible for systemic sclerosis is a colossal task. By looking at immune cells such as macrophages, we can generate specific hypotheses that will allow us to understand how these cells cause damage,” Jacques Behmoaras, co-lead author of the study said in a press release. Behmoaras is a principal investigator at the Centre for Complement and Inflammation Research, Imperial College London,

“In the long quest for finding therapies for systemic sclerosis, our findings have implications for understanding the genetic basis of the disease, and we believe our discovery will prompt detailed functional studies in macrophages and immune cells, hopefully providing a starting point to develop greatly needed treatments for this disease” added Enrico Petretto, PhD, study co-lead author and associate professor at Duke-NUS Medical School (Duke-NUS).

The study also revealed hundreds of genes that previously were not known to be associated with systemic sclerosis.

 

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.
×
Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.
Latest Posts
  • Lenabasum
  • Scleroderma Lung Study enrolling
  • scleroderma risk, FLI1
  • stem cell transplant

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?